FOLFIRINOX

Colorectal cancer

Adenocarcinoma

Surgery

Pancreatic cancer

Radiology

Retrospective cohort study

Oxaliplatin

Internal medicine

Confidence interval

Oncology

Medicine

General surgery

Cancer

Therapeutic Advances in Medical Oncology

Despite the scarcity of data based on randomized trials, FOLFIRINOX is widely used in the management of borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC). We investigated the clinical outcomes of neoadjuvant FOLFIRINOX in patients with BRPC and LAPC.

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma